Thrivent Financial for Lutherans’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11M Buy
95,787
+26
+0% +$324 ﹤0.01% 1830
2025
Q4
$1.09M Sell
95,761
-8,933
-9% -$105K ﹤0.01% 1873
2025
Q3
$1.33M Sell
104,694
-73,793
-41% -$1.07M ﹤0.01% 1600
2025
Q2
$2.83M Buy
178,487
+318
+0.2% +$4.76K 0.01% 1128
2025
Q1
$2.66M Sell
178,169
-15,133
-8% -$268K 0.01% 1107
2024
Q4
$3.67M Sell
193,302
-109,095
-36% -$2.31M 0.01% 1059
2024
Q3
$8.18M Sell
302,397
-50,797
-14% -$1.3M 0.02% 746
2024
Q2
$8.8M Buy
353,194
+27,708
+9% +$795K 0.02% 697
2024
Q1
$10.8M Buy
325,486
+4,299
+1% +$147K 0.02% 630
2023
Q4
$11.4M Sell
321,187
-41,086
-11% -$1.3M 0.02% 595
2023
Q3
$12.4M Buy
362,273
+317,489
+709% +$12.1M 0.03% 544
2023
Q2
$1.79M Sell
44,784
-194
-0.4% -$7.71K ﹤0.01% 1413
2023
Q1
$1.77M Sell
44,978
-764
-2% -$28K ﹤0.01% 1384
2022
Q4
$1.46M Sell
45,742
-83,371
-65% -$2.51M ﹤0.01% 1484
2022
Q3
$3.66M Buy
129,113
+92
+0.1% +$3.15K 0.01% 909
2022
Q2
$4.61M Buy
129,021
+98,546
+323% +$3.99M 0.01% 845
2022
Q1
$1.5M Sell
30,475
-43,704
-59% -$2.31M ﹤0.01% 1519
2021
Q4
$4.14M Sell
74,179
-6,197
-8% -$341K 0.01% 978
2021
Q3
$4.67M Buy
80,376
+70,819
+741% +$4.37M 0.01% 918
2021
Q2
$605K Buy
9,557
+19
+0.2% +$1.25K ﹤0.01% 2108
2021
Q1
$609K Sell
9,538
-33
-0.3% -$1.91K ﹤0.01% 2154
2020
Q4
$501K Sell
9,571
-355
-4% -$17.5K ﹤0.01% 2134
2020
Q3
$434K Sell
9,926
-207
-2% -$9.15K ﹤0.01% 2038
2020
Q2
$446K Sell
10,133
-4
-0% -$169 ﹤0.01% 1963
2020
Q1
$394K Hold
10,137
﹤0.01% 1846
2019
Q4
$574K Sell
10,137
-45
-0.4% -$2.51K ﹤0.01% 1826
2019
Q3
$543K Sell
10,182
-359
-3% -$19.3K ﹤0.01% 1793
2019
Q2
$615K Buy
10,541
+592
+6% +$31.8K ﹤0.01% 1700
2019
Q1
$493K Buy
9,949
+9
+0.1% +$396 ﹤0.01% 1812
2018
Q4
$370K Buy
9,940
+175
+2% +$6.37K ﹤0.01% 1728
2018
Q3
$369K Buy
9,765
+215
+2% +$8.95K ﹤0.01% 1809
2018
Q2
$418K Sell
9,550
-35
-0.4% -$1.64K ﹤0.01% 1770
2018
Q1
$482K Buy
9,585
+276
+3% +$16.3K ﹤0.01% 1656
2017
Q4
$613K Sell
9,309
-44,661
-83% -$2.84M ﹤0.01% 1556
2017
Q3
$3.23M Buy
53,970
+430
+0.8% +$25.6K 0.01% 725
2017
Q2
$3.47M Sell
53,540
-230,300
-81% -$14.5M 0.01% 684
2017
Q1
$17.7M Sell
283,840
-42,150
-13% -$2.54M 0.08% 251
2016
Q4
$18.8M Sell
325,990
-37,760
-10% -$2.23M 0.08% 247
2016
Q3
$21.6M Buy
363,750
+76,980
+27% +$4.73M 0.1% 209
2016
Q2
$17.8M Sell
286,770
-320
-0.1% -$19.7K 0.08% 237
2016
Q1
$17.7M Sell
287,090
-194,990
-40% -$11.5M 0.09% 222
2015
Q4
$29.3M Buy
+482,080
New +$28.7M 0.14% 155
2014
Q4
Sell
-112,950
Closed -$5.15M 1914
2014
Q3
$5.15M Buy
112,950
+1,150
+1% +$54.1K 0.03% 461
2014
Q2
$5.29M Buy
111,800
+1,100
+1% +$51.2K 0.03% 480
2014
Q1
$5.1M Buy
110,700
+5,000
+5% +$231K 0.03% 439
2013
Q4
$5.12M Buy
+105,700
New +$4.95M 0.03% 438
2013
Q3
Sell
-5,000
Closed -$205 1619
2013
Q2
$205 Buy
+5,000
New +$208K ﹤0.01% 1426

Other funds holding XRAY

Thrivent Financial for Lutherans's XRAY Position: Q1 2026 in Review

Thrivent Financial for Lutherans increased its Dentsply Sirona (XRAY) stake by 0.03% in Q1 2026, buying an estimated $324 and bringing the position to 95,787 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1830.

Thrivent Financial for Lutherans first reported a position in XRAY in Q2 2013 and has held it in 47 quarters since. The position peaked at $29.3M in Q4 2015. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Thrivent Financial for Lutherans held 95,787 shares of Dentsply Sirona worth $1.11M as of Q1 2026.
  • Thrivent Financial for Lutherans bought 26 Dentsply Sirona shares in Q1 2026, an estimated $324.
  • Dentsply Sirona made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #1830 holding.
  • Thrivent Financial for Lutherans first reported a position in Dentsply Sirona in Q2 2013 and has held it in 47 quarters since.
  • Thrivent Financial for Lutherans's Dentsply Sirona position peaked at $29.3M in Q4 2015.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.